Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antisense Therapy for Cardiovascular Diseases.

Current pharmaceutical design - 1 Jan 2015

Phillips M Ian, Costales Jessica, Lee Robert J, Oliveira Edilamar, Burns Andrew B

Abstract excerpt

Antisense oligonucleotide therapy is a growing field in cardiac, metabolic, and muscular diseases. This precision therapy allows for treatment of diseases due to specific genetic defects. Antisense has few side effects and is relatively long lasting. Some major targets for antisense therapy include hyperglycemia, hyperlipidemia, and hypercholesterolemia. ISIS Pharmaceuticals recently commercialized antisense...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Exons
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oligonucleotides, Antisense

Source

Identifiers

PMID: 26234793
DOI: 10.2174/1381612821666150803150402

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antisense Therapy for Cardiovascular Diseases.PMID 26234793Read ↗

Antisense technology: A reviewSemantic proximity Read ↗

RNA therapeutics for cardiovascular diseaseSemantic proximity Read ↗

RNA Therapeutics – The Next Generation of Drugs for Cardiovascular DiseasesSemantic proximity Read ↗

Advances in nucleic acid-targeted therapies for cardiovascular disease preventionSemantic proximity Read ↗

Antisense Oligonucleotide Therapy for Inherited Retinal Dystrophies.Semantic proximity Read ↗

The Role of Antisense Oligonucleotide Therapy in Patients with Familial Hypercholesterolemia: Risks, Benefits, and Management RecommendationsSemantic proximity Read ↗

Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutations.Semantic proximity Read ↗

Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic.Semantic proximity Read ↗

Targeting RNA : A Transformative Therapeutic StrategySemantic proximity Read ↗

Antisense oligonucleotide therapeutics targeting age-related diseasesSemantic proximity Read ↗

Present and future of antisense therapy for splicing modulation in inherited metabolic diseaseSemantic proximity Read ↗

Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.